Coram Report issue

For profit Phase 4
Founded: Denver CO United States (1988)
Status: Acquired by CVS Health (2013)

Organization Overview

First Clinical Trial
2006
NCT00313144
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 4 Trials (1)

alpha-1 antitrypsin (Prolastin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

alpha 1-Antitrypsin Deficiency (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1